Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
for Amyotrophic Lateral Sclerosis
Drug: Masitinib
Sites in Burlington +5 more locations
Sponsor: AB Science
Sex: All·Age: 18 - 81
Code: NCT03127267·Phase 3·Recruiting·Listed Apr 2017